[Hepatic toxicity in HER-2(+) breast cancer patient under treatment with capecitabine and lapatinib].

Subjects

Subjects :

Adult
Antimetabolites, Antineoplastic therapeutic use
Antineoplastic Agents therapeutic use
Breast Neoplasms drug therapy
Capecitabine therapeutic use
Carcinoma, Ductal, Breast drug therapy
Female
Humans
Lapatinib
Quinazolines therapeutic use
Antimetabolites, Antineoplastic adverse effects
Antineoplastic Agents adverse effects
Breast Neoplasms complications
Breast Neoplasms genetics
Capecitabine adverse effects
Carcinoma, Ductal, Breast complications
Carcinoma, Ductal, Breast genetics
Chemical and Drug Induced Liver Injury etiology
Quinazolines adverse effects
Receptor, ErbB-2 genetics

Details

Language :

Spanish; Castilian

ISSN :

2171-8695

Volume :

40

Issue :

2

Database :

MEDLINE

Journal :

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Publication Type :

Academic Journal

Accession number :

26980172

Full Text :

https://doi.org/10.7399/fh.2016.40.2.9360